JP2022507295A5 - - Google Patents
Info
- Publication number
- JP2022507295A5 JP2022507295A5 JP2021525789A JP2021525789A JP2022507295A5 JP 2022507295 A5 JP2022507295 A5 JP 2022507295A5 JP 2021525789 A JP2021525789 A JP 2021525789A JP 2021525789 A JP2021525789 A JP 2021525789A JP 2022507295 A5 JP2022507295 A5 JP 2022507295A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable domain
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767509P | 2018-11-14 | 2018-11-14 | |
| US62/767,509 | 2018-11-14 | ||
| US201962820718P | 2019-03-19 | 2019-03-19 | |
| US62/820,718 | 2019-03-19 | ||
| US201962886872P | 2019-08-14 | 2019-08-14 | |
| US62/886,872 | 2019-08-14 | ||
| US201962931746P | 2019-11-06 | 2019-11-06 | |
| US62/931,746 | 2019-11-06 | ||
| PCT/US2019/061278 WO2020102422A1 (en) | 2018-11-14 | 2019-11-13 | THERAPEUTIC SIRPα ANTIBODIES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022507295A JP2022507295A (ja) | 2022-01-18 |
| JP2022507295A5 true JP2022507295A5 (cg-RX-API-DMAC7.html) | 2022-11-21 |
Family
ID=70730617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525789A Withdrawn JP2022507295A (ja) | 2018-11-14 | 2019-11-13 | 治療用SIRPα抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11202828B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3880239A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022507295A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113573728A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019380503A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021009325A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3119748A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020102422A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12018550160B1 (en) | 2016-04-14 | 2024-07-03 | Ose Immunotherapeutics | NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS |
| JOP20190009A1 (ar) | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها |
| WO2019183266A1 (en) | 2018-03-21 | 2019-09-26 | ALX Oncology Inc. | Antibodies against signal-regulatory protein alpha and methods of use |
| CN112574310B (zh) * | 2020-12-11 | 2023-05-05 | 浙江博锐生物制药有限公司 | 抗SIRPα抗体及其用途 |
| US20240101716A1 (en) * | 2020-12-18 | 2024-03-28 | La Nova Medicines Development Co., Ltd. | BISPECIFIC ANTIBODIES TARGETING SIRPa AND PD-L1 |
| WO2022247933A1 (zh) * | 2021-05-28 | 2022-12-01 | 百奥泰生物制药股份有限公司 | 抗SIPRα抗体及其应用 |
| AU2022284373A1 (en) * | 2021-06-04 | 2024-01-04 | Boehringer Ingelheim International Gmbh | Anti-sirp-alpha antibodies |
| CN113956363B (zh) | 2021-10-13 | 2023-03-31 | 宜明昂科生物医药技术(上海)股份有限公司 | 靶向cd47和cd24的重组融合蛋白及其制备和用途 |
| CN117447592B (zh) * | 2022-07-26 | 2024-05-28 | 北京东方百泰生物科技股份有限公司 | 一种抗Siglec-15单克隆抗体、其抗原结合片段及其应用 |
| CN115819586B (zh) * | 2022-10-13 | 2023-10-31 | 珠海市丽珠单抗生物技术有限公司 | 抗人SIRPα单克隆抗体及其用途 |
| WO2024105180A1 (en) | 2022-11-16 | 2024-05-23 | Boehringer Ingelheim International Gmbh | Predictive efficacy biomarkers for anti-sirpa antibodies |
| JP2026512425A (ja) | 2023-03-30 | 2026-04-16 | オーエスイー・イミュノセラピューティクス | 免疫細胞増強分子の発現のための活性化免疫細胞に標的化された脂質ベースのナノ粒子及びその使用 |
| WO2024200820A1 (en) | 2023-03-30 | 2024-10-03 | Ose Immunotherapeutics | Method of synthesis of targeted lipid nanoparticle and uses thereof |
| WO2024220895A1 (en) * | 2023-04-20 | 2024-10-24 | Twist Bioscience Corporation | Antibodies and variant nucleic acid libraries for sirp-alpha |
| CN116514980B (zh) * | 2023-04-23 | 2025-12-16 | 杭州美赛生物医药科技有限公司 | 抗SIRPα抗体及其应用 |
| CN118047874B (zh) * | 2024-02-19 | 2025-02-18 | 中科德佑(山西)生物科技有限公司 | 一种双特异性抗体及其与t细胞在制备治疗肿瘤药物中的应用 |
| CN118791601B (zh) * | 2024-07-24 | 2025-11-14 | 苏州大学 | 一株可改善结核分枝杆菌耐药性的抗Rv0340单克隆抗体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4128089A (en) * | 1988-09-15 | 1990-03-22 | Rorer International (Overseas) Inc. | Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| PH12013501137A1 (en) * | 2010-12-08 | 2021-06-02 | Abbvie Stemcentrx Llc | Novel modulators and methods of use |
| MX350335B (es) * | 2011-08-17 | 2017-09-04 | Univ California | Anticuerpos que enlazan alfa-v beta-8 integrina. |
| HRP20190122T1 (hr) * | 2011-11-16 | 2019-03-08 | Adrenomed Ag | Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću |
| BR112014017814A8 (pt) | 2012-01-20 | 2017-07-11 | Genzyme Corp | Anticorpos anti-cxcr3 |
| CN116425875A (zh) * | 2015-09-18 | 2023-07-14 | 安驰肿瘤公司 | 治疗性cd47抗体 |
| JOP20190009A1 (ar) * | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها |
| KR102642385B1 (ko) | 2017-02-06 | 2024-03-04 | 오리오니스 바이오사이언시스 엔브이 | 표적화된 키메라 단백질 및 이의 용도 |
| PT3443010T (pt) * | 2017-02-17 | 2024-10-21 | Ose Immunotherapeutics | Novos anticorpos anti-sirpa e suas aplicações terapêuticas |
| JP7160833B2 (ja) * | 2017-04-13 | 2022-10-25 | サイロパ ビー.ブイ. | 抗sirpアルファ抗体 |
-
2019
- 2019-11-13 BR BR112021009325-7A patent/BR112021009325A2/pt not_active Application Discontinuation
- 2019-11-13 CA CA3119748A patent/CA3119748A1/en not_active Withdrawn
- 2019-11-13 JP JP2021525789A patent/JP2022507295A/ja not_active Withdrawn
- 2019-11-13 AU AU2019380503A patent/AU2019380503A1/en not_active Withdrawn
- 2019-11-13 EP EP19885043.0A patent/EP3880239A4/en not_active Withdrawn
- 2019-11-13 US US16/682,893 patent/US11202828B2/en active Active
- 2019-11-13 CN CN201980087951.8A patent/CN113573728A/zh not_active Withdrawn
- 2019-11-13 WO PCT/US2019/061278 patent/WO2020102422A1/en not_active Ceased
-
2021
- 2021-11-24 US US17/534,774 patent/US20220226469A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11858991B2 (en) | LAG-3-binding molecules and methods of use thereof | |
| US11202828B2 (en) | Therapeutic SIRP-α antibodies | |
| JP6955507B2 (ja) | Pd‐1及びctla‐4との免疫応答性を有する二重特異性並びにその使用方法 | |
| US20220025050A1 (en) | Bifunctional molecule directed against human pd-1 | |
| US11167029B2 (en) | Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy | |
| JP2019500892A5 (cg-RX-API-DMAC7.html) | ||
| KR20180093127A (ko) | Pd-1-결합 분자 및 그것의 사용 방법 | |
| JP2019500891A5 (cg-RX-API-DMAC7.html) | ||
| RU2018126297A (ru) | Антитела, нацеленные на cd32b, и способы их применения | |
| JP7480307B2 (ja) | 免疫細胞関与効果を調節するための手段および方法 | |
| JP2023543896A5 (cg-RX-API-DMAC7.html) | ||
| US20230279108A1 (en) | Therapeutic sirp-alpha antibodies | |
| EP4304724A1 (en) | Combination therapy of pd-1-targeted il-2 variant immunoconjugate and anti-tyrp1/anti-cd3 bispecific antibodies | |
| WO2023147331A1 (en) | Bispecific molecule with tunable affinity to a targetted antigen | |
| JP2023517889A5 (cg-RX-API-DMAC7.html) | ||
| JP7378567B2 (ja) | Lag‐3結合分子及びその使用方法 | |
| BR112017026330B1 (pt) | Molécula de ligação de lag-3 que compreende um domínio de ligação a lag-3 capaz de se ligar tanto ao lag-3 humano quanto ao lag-3 de macaco cynomolgus |